These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7038207)

  • 21. Effect of homoharringtonine on proliferation and differentiation of human leukemic cells in vitro.
    Zhou JY; Chen DL; Shen ZS; Koeffler HP
    Cancer Res; 1990 Apr; 50(7):2031-5. PubMed ID: 2317793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia.
    Park CH; Amare M; Morrison FS; Maloney TR; Goodwin JW
    Cancer Treat Rep; 1982 Jun; 66(6):1257-61. PubMed ID: 7083232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell proliferation in acute promyelocytic leukemia. Studies with thymidine labeling and in vitro colony assay.
    Tura S; Baccarani M; Santucci MA; Ricci P
    Haematologica; 1982 Jun; 67(3):349-55. PubMed ID: 6814992
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative studies on the in vitro killing of human normal and leukemic clonogenic cells (CFUc) by daunorubicin, daunorubicinol, and daunorubicin-DNA complex.
    Beran M; Andersson B; Eksborg S; Ehrsson H
    Cancer Chemother Pharmacol; 1979; 2(1):19-24. PubMed ID: 498414
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro growth and clinical response of leukemia cells to macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in acute leukemia].
    Takeyama H; Kajiguchi T; Miyata Y; Saito M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):873-8. PubMed ID: 10897214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin.
    Morris KL; Adams JA; Liu Yin JA
    Leuk Res; 2009 Aug; 33(8):1096-9. PubMed ID: 19268363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro assessment of drug sensitivity in acute nonlymphocytic leukemia.
    Preisler HD; Raza A
    Recent Results Cancer Res; 1984; 94():102-15. PubMed ID: 6593774
    [No Abstract]   [Full Text] [Related]  

  • 29. Nucleus labeling or membrane labeling for studying the proliferation of drug treated cells?
    Boutonnat J; Barbier M; Ronot X; Seigneurin D
    Morphologie; 2000 Jun; 84(265):11-5. PubMed ID: 11048293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro hematopoiesis following induction chemotherapy for acute leukemia.
    Beyer GS; Bruno E; Hoffman R
    Cancer Res; 1985 Nov; 45(11 Pt 2):5921-5. PubMed ID: 4053063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric Oncology Group Study of in vitro clonal growth patterns of leukemic cells in childhood acute nonlymphocytic leukemia as a predictor of induction response.
    Findley HW; Steuber CP; Krischer JP; Ragab AH
    Cancer Res; 1987 Aug; 47(15):4225-8. PubMed ID: 3607762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
    Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
    Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of continuous infusion of cytosine arabinoside on sequencing with daunorubicin in L1210 leukemia.
    Edelstein M; Valeriote F; Vietti T
    Cancer Treat Rep; 1978 Apr; 62(4):547-8. PubMed ID: 657151
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man.
    Buick RN; Messner HA; Till JE; McCulloch EA
    J Natl Cancer Inst; 1979 Feb; 62(2):249-55. PubMed ID: 310906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Low-dose cytosine arabinoside therapy in relapsed acute leukemia: correlation of clinical response and in vitro sensitivity tests].
    Ninomiya T; Hirose M; Takaue Y; Watanabe T; Ouchi T; Sato J; Koyama T; Abe T; Suzue T
    Rinsho Ketsueki; 1987 Oct; 28(10):1763-70. PubMed ID: 3452642
    [No Abstract]   [Full Text] [Related]  

  • 36. DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.
    Wilmanns W
    Natl Cancer Inst Monogr; 1971 Dec; 34():153-9. PubMed ID: 5291099
    [No Abstract]   [Full Text] [Related]  

  • 37. Recruitment of quiescent tumor by humoral stimulatory activity: requirements for successful chemotherapy.
    Burke PJ; Karp JE; Vaughan WP; Sanford PL
    Blood Cells; 1982; 8(3):519-33. PubMed ID: 7159763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy.
    Tardi P; Johnstone S; Harasym N; Xie S; Harasym T; Zisman N; Harvie P; Bermudes D; Mayer L
    Leuk Res; 2009 Jan; 33(1):129-39. PubMed ID: 18676016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro short-term sensitivity test for the prediction of response to chemotherapy in acute non-lymphocytic leukemia.
    Saccardi R; Bernabei PA; Bezzini R; Agostino FC; Leoni F; Rossi Ferrini P
    Chemioterapia; 1988 Jun; 7(3):173-8. PubMed ID: 3168072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The response of cells to anti-tumour drugs estimated by limiting dilution in microwell culture].
    Wan JH; Morley AA
    Yao Xue Xue Bao; 1985 Jun; 20(6):418-22. PubMed ID: 3868292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.